Transcriptomics

Dataset Information

3

Major gene partners of a favorable biomarker in ER(+) breast cancer


ABSTRACT: Background: We have established a statistical approach on building a transcriptional regulatory network in silico at a global transcriptome scale. Here, we characterize clinical relevant gene activities regulated by a transcription factor-estrogen-related receptor gamma (ESRRG) via such approach. Methods: We measured gene expression relationship between ESRRG and its target gene via univariate coefficient of intrinsic dependence and Galton Pearson’s correlation coefficient. A few more bioinformatics tools were used for further investigation on ESRRG. Results: ESRRG is a negative determinant of lymphovascular invasion, lymph nodal category, stage, histological grade, nuclear pleomorphism and tubule formation in ER(+) infiltrating ductal carcinoma of breast. Interestingly, ESRRG was the only one in the final intersection of Venn Diagram analyses for determinants of those clinical indices. We established an ESRRG core network consisting of 118 probes. Both MYB and ARNT2 were up-regulated by ESRRG and in two ESRRG subnetworks (29 probes, 89 probes), respectively. We observed genes for tumor suppressive activities and responsiveness to anticancer treatments within ESRRG core network and a conserved protective role of ESRRG. Conclusions: ESRRG is a tumor suppressor typically for ER(+) breast cancer and up-regulates tumor suppressor genes mostly within ERα transcriptional regulatory network. An ESRRG core network reveals ESRRG to be a favorable marker and MYB to be the main partner for its cancer protective role during early tumor promotion. But, ARNT2 is an additional partner of ESRRG during early tumor progression. Impact: A core ESRRG transcriptional regulatory network indicates the major clinical impact of ESRRG. 181 surgical specimens of primary infiltrating ductal carcinoma (IDC) were obtained from patients who underwent surgery at National Taiwan University Hospital (NTUH) between 1998 and 2007. They include 90 ER(+) IDCs and 91 ER(-) IDCs. Tissue samples were excised, snap frozen in liquid nitrogen, and stored at -80℃. Breast cancer samples containing relatively pure cancer as defined by greater than 50% tumor cells per high-power field examined in an adjacent section of tumor sample were for this study (Lien HC, et al. Oncogene 2007; 26: 7859-71). Twenty five non-tumor samples were surgically taken from breast cancer patients in 181 IDC patients to generate 25 gene expression profiles as a control in this study. All patients had given informed consent according to the guidelines approved by the Institutional Review Board at NTUH. The matrix file linked to the bottom of this Series includes reanalyzed data from the 119 Samples of this Series and 87 Samples from Series GSE9309 and GSE17040.

ORGANISM(S): Homo sapiens  

SUBMITTER: King-Jen Chang   Wen-Hung Kuo  Li-Yun Chang  Fon-Jou Hsieh  Li-Yu D Liu  Hsiao-Lin Hwa 

PROVIDER: E-GEOD-24124 | ArrayExpress | 2010-11-04

SECONDARY ACCESSION(S): GSE24124PRJNA130065

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2010-11-04 | GSE24124 | GEO
2012-09-25 | E-GEOD-32641 | ArrayExpress
| GSE87517 | GEO
| GSE98330 | GEO
| GSE53566 | GEO
2010-12-24 | GSE26304 | GEO
2010-12-24 | E-GEOD-26304 | ArrayExpress
2014-08-11 | E-GEOD-55374 | ArrayExpress
2009-02-01 | GSE10197 | GEO
| GSE79378 | GEO